Phumla Sinxadi - Concepedia

Author

Phumla Sinxadi

University of Cape Town ORCID

Also Known As

P Sinxadi, Phumla Sinxadi, Phumla Z Sinxadi, Phumla Z. Sinxadi, Phumla Zuleika Sinxadi

Publications

767

Citations

H-Index

Concepts

All Affiliations

University of Cape Town University of the Witwatersrand Vanderbilt University Medical Center Wellcome Centre for Infectious Diseases Research in Africa Meharry Medical College

About

Phumla Sinxadi is an author at University of Cape Town specializing in medicine, epidemiology, and genetic epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	51
2	Public Health	2	2	33
3	Epidemiology	2	2	33
4	African American Studies	1	1	18
5	African Studies	1	1	18

Phumla Sinxadi

Publications

582

Citations

H-Index

Page 1

	Year	Citations
Pharmacogenetics of plasma efavirenz exposure in HIV‐infected adults and children in South Africa Phumla Sinxadi, Paul Leger, Helen McIlleron, British Journal of Clinical Pharmacology	2015	81
<i>CYP2B6</i> Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz Rulan Griesel, Gary Maartens, Maxwell Chirehwa, Clinical Infectious Diseases	2020	81
Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel <i>Plasmodium</i> Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers Phumla Sinxadi, Cristina Donini, Hilary Johnstone, Antimicrobial Agents and Chemotherapy	2020	58
Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype Helen McIlleron, Michael Schomaker, Yuan Ren, AIDS	2013	53
Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens Michael Leonard, Zinhle Cindi, Yuki Bradford, Clinical Infectious Diseases	2020	50
Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations Phumla Sinxadi, Helen McIlleron, Joel A. Dave, Medicine	2016	41
A Comparison of Plasma Efavirenz and Tenofovir, Dried Blood Spot Tenofovir-Diphosphate, and Self-Reported Adherence to Predict Virologic Suppression Among South African Women Tamsin K. Phillips, Phumla Sinxadi, Elaine J. Abrams, JAIDS Journal of Acquired Immune Deficiency Syndromes	2019	37
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens Simiso Sokhela, François Venter, Bronwyn Bosch, Open Forum Infectious Diseases	2024	29
Mitochondrial Genomics and Antiretroviral Therapy-Associated Metabolic Complications in HIV-Infected Black South Africans: A Pilot Study Phumla Sinxadi, Joel A. Dave, David C. Samuels, AIDS Research and Human Retroviruses	2013	19
Understanding the Implications of Mitochondrial DNA Variation in the Health of Black Southern African Populations: The 2014 Workshop Francois H. van der Westhuizen, Phumla Sinxadi, Collet Dandara, Human Mutation Genetic TestingMtdna VariationGenetic EpidemiologyClinical GeneticsHuman Phenotypes	2015	18

Page 1